5:03 PM
Oct 25, 2013
 |  BC Extra  |  Financial News

Recro files for IPO

Pain company Recro Pharma Inc. (Malvern, Pa.) filed to raise up to $28 million in an IPO underwritten by Aegis Capital. Recro's Dex-IN is an intranasal formulation of dexmedetomidine, a selective

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >